1. Home
  2. RCKT vs FOF Comparison

RCKT vs FOF Comparison

Compare RCKT & FOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • FOF
  • Stock Information
  • Founded
  • RCKT 1999
  • FOF 2006
  • Country
  • RCKT United States
  • FOF United States
  • Employees
  • RCKT N/A
  • FOF N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • FOF Investment Managers
  • Sector
  • RCKT Health Care
  • FOF Finance
  • Exchange
  • RCKT Nasdaq
  • FOF Nasdaq
  • Market Cap
  • RCKT 328.6M
  • FOF 354.8M
  • IPO Year
  • RCKT N/A
  • FOF N/A
  • Fundamental
  • Price
  • RCKT $3.28
  • FOF $13.11
  • Analyst Decision
  • RCKT Buy
  • FOF
  • Analyst Count
  • RCKT 13
  • FOF 0
  • Target Price
  • RCKT $12.96
  • FOF N/A
  • AVG Volume (30 Days)
  • RCKT 5.9M
  • FOF 58.7K
  • Earning Date
  • RCKT 11-06-2025
  • FOF 01-01-0001
  • Dividend Yield
  • RCKT N/A
  • FOF 9.07%
  • EPS Growth
  • RCKT N/A
  • FOF N/A
  • EPS
  • RCKT N/A
  • FOF N/A
  • Revenue
  • RCKT N/A
  • FOF N/A
  • Revenue This Year
  • RCKT N/A
  • FOF N/A
  • Revenue Next Year
  • RCKT $108.43
  • FOF N/A
  • P/E Ratio
  • RCKT N/A
  • FOF N/A
  • Revenue Growth
  • RCKT N/A
  • FOF N/A
  • 52 Week Low
  • RCKT $2.19
  • FOF $9.59
  • 52 Week High
  • RCKT $22.01
  • FOF $11.75
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 51.09
  • FOF 61.26
  • Support Level
  • RCKT $3.16
  • FOF $12.99
  • Resistance Level
  • RCKT $3.40
  • FOF $13.12
  • Average True Range (ATR)
  • RCKT 0.27
  • FOF 0.09
  • MACD
  • RCKT -0.01
  • FOF -0.01
  • Stochastic Oscillator
  • RCKT 32.79
  • FOF 88.09

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About FOF Cohen & Steers Closed-End Opportunity Fund Inc.

Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. Its investment objective is to achieve a total return, consisting of high current income and potential capital appreciation.

Share on Social Networks: